Abstract
In the UK, adverse drug reactions (ADRs) are responsible for over 6.5% of all hospital admissions, representing a significant morbidity and cost burden to the health service. We aimed to develop an ADR monitoring system capable of identifying the reasons for patient discontinuation of drug therapy within 6 months of the index prescription.
Original language | English |
---|---|
Pages (from-to) | 244-9 |
Number of pages | 6 |
Journal | British Journal of Clinical Pharmacology |
Volume | 71 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2011 |